Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 064042/0527 | |
| Pages: | 8 |
| | Recorded: | 06/23/2023 | | |
Attorney Dkt #: | 16425-000039-US-NP |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18269379
|
Filing Dt:
|
06/23/2023
|
Publication #:
|
|
Pub Dt:
|
03/07/2024
| | | | |
Title:
|
PHARMACEUTICAL COMPOSITION COMPRISING TADALAFIL OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF AND DUTASTERIDE OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF EXHIBITING NOVEL DISSOLUTION RATE
|
|
Assignee
|
|
|
7, TEHERAN-RO 108-GIL, GANGNAM-GU |
SEOUL, KOREA, REPUBLIC OF 06175 |
|
Correspondence name and address
|
|
HARNESS, DICKEY & PIERCE, PLC
|
|
7700 BONHOMME, SUITE 400
|
|
SAINT LOUIS, MO 63105
|
Search Results as of:
09/25/2024 09:49 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|